|
Garcia-Villalba J, Hurtado-Navarro L, Penin-Franch A, Molina-Lopez C, Martinez-Alarcon L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol. 2022 May 18;13:894470. doi: 10.3389/fimmu.2022.894470. eCollection 2022. PubMed PMID: 35663992; PubMed Central PMCID: PMC9161710.
AÑO: 2022; IF: 7.3
|
35663992
|
Weber ANR, Tapia-Abellan A, Liu X, Dickhofer S, Arostegui JI, Pelegrin P, Welzel T, Kuemmerle-Deschner JB. Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3. Rheumatology (Oxford). 2022 Oct 6;61(10):e299-e313. doi: 10.1093/rheumatology/keac273. No abstract available. PubMed PMID: 35579347.
AÑO: 2022; IF: 5.5
|
|
Angosto-Bazarra D, Molina-Lopez C, Penin-Franch A, Hurtado-Navarro L, Pelegrin P. Techniques to Study Inflammasome Activation and Inhibition by Small Molecules. Molecules. 2021 Mar 18;26(6):1704. doi: 10.3390/molecules26061704. PubMed PMID: 33803783; PubMed Central PMCID: PMC8003184.
AÑO: 2021; IF: 4.927
|
|
Andreeva L, David L, Rawson S, Shen C, Pasricha T, Pelegrin P, Wu H. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell. 2021 Dec 22;184(26):6299-6312.e22. doi: 10.1016/j.cell.2021.11.011. Epub 2021 Dec 2. PubMed PMID: 34861190; PubMed Central PMCID: PMC8763037.
AÑO: 2021; IF: 66.85
|
|
Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4. PubMed PMID: 32763266; PubMed Central PMCID: PMC7749849.
AÑO: 2021; IF: 30.083
|